Zach Hiser, testicular cancer survivor and his wife

Urologic Cancer

The U-M Health Rogel Cancer Center brings together a multidisciplinary team working to improve the diagnosis and treatment of urologic cancers, such as bladder, kidney and prostate cancer.

Call for an appointment: 734-647-8902

The Rogel Cancer Center and Michigan Medicine's Urology Department assembled a multidisciplinary team of doctors and researchers working together to improve the diagnosis and treatment of urologic cancers, such as bladder, kidney and prostate cancer.

Our patients have access to treatment options that include robotic surgery, genetic sequencing for more advanced or high risk prostate cancer patients, active surveillance, the latest in radiation techniques and all phases of clinical trials. Our multidisciplinary tumor board meets once a week to discuss patients care plans to offer the most optimal treatment option.

Looking for a Doctor or Location?

Find a Doctor

Locations

Our Expertise Includes

Learn about clinical trials

Discover how clinical trials at the Rogel Cancer Center are driving the future of cancer care. Our researchers work every day to find better ways to detect, treat, prevent cancer, and clinical trials are a key part of that progress.

Browse Open Trials

Questions about cancer?

Contact our Cancer AnswerLine™ at 800-865-1125. You'll talk to a nurse with years of experience in cancer care.

Learn More

News & Stories

Microscope images of prostate cancer cells

Health Lab

New drug combination may help treat advanced prostate cancer

University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors may slow the growth of treatment-resistant prostate cancer by targeting transdifferentiated tumors.

Health Lab

Researchers create new path to target hard-to-drug prostate cancer protein

University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.

cup sample with orange top in front of toilet

Health Lab

Urine-based test detects aggressive prostate cancer

Researchers at have validated a previously developed urine test, which can potentially bypass invasive procedures for prostate cancer detection among men who are unlikely to benefit.

group of medical teammates huddled around the MRI machine

Health Lab

New prostate biopsy technique shows potential future of MRI

Michigan Medicine specialists are investigating new in-bore, MRI-guided prostate biopsy techniques, which can help patients not served by standard methods.

Cancer Aware

Pathology’s Role in Cancer Care

After a patient has a biopsy, the samples are sent to pathology to determine if it is cancerous or not as well as how aggressive it is. Many patients will see their results before hearing from the medical team in their patient portal – leaving them anxious or confused on what it all means. Pathologist, Dr. Cathyrn Lapedis, talks about the role of pathology in a patient’s care plan, as well as new ways to help patients when they get results before their physician is able go over to help them with anxiety and to be better informed about their potential diagnosis.

ribbons in colorful colors lined up next to eachother

Health Lab

5-year survival rate has increased for all cancers, according to American Cancer Society

The American Cancer Society reports that mortality rates have continued to decline since the 1990s. N. Lynn Henry, of Michigan Medicine, answers questions about how factors such as healthy lifestyle choices, early screening and clinical trials have improved cancer survival rates.